Prophylactic fluconazole is effective in preventing fungal colonization and fungal systemic infections in preterm neonates: A single-center, 6-year, retrospective cohort study

Pediatrics

Volumn 117, Issue 1, 2006, Pages

  Manzoni, Paolo ^a   Arisio, Riccardo ^a   Mostert, Michael ^a   Leonessa, Marialisa ^a   Farina, Daniele ^a   Latino, Maria Agnese ^a   Gomirato, Giovanna ^a  

^a CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

Author keywords

Candida; Colonization; Fluconazole; Infection; Prophylaxis; Very low birth weight infant

Indexed keywords

ANTIBIOTIC AGENT; CEPHALOSPORIN; FLUCONAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; VANCOMYCIN; ANTIFUNGAL AGENT;

BIRTH WEIGHT; CANDIDA; COHORT ANALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FUNGAL COLONIZATION; FUNGUS CULTURE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; NEWBORN; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; REVIEW; SINGLE DRUG DOSE; ARTICLE; ASPERGILLOSIS; CANDIDIASIS; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; VERY LOW BIRTH WEIGHT;

ANTIFUNGAL AGENTS; ASPERGILLOSIS; CANDIDA; CANDIDIASIS; FLUCONAZOLE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; MICROBIAL SENSITIVITY TESTS;

EID: 32544455059     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2004-2227     Document Type: Review

References (43)

1. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics. 2002;109:34-39
2. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110:285-291
3. Kossoff EH, Buescher ES, Karlowicz MG. Candidemia in a neonatal intensive care unit: trends during fifteen years and clinical features of 111 cases. Pediatr Infect Dis J. 1998;17:504-508
4. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. The National Epidemiology of Mycosis Survey Study Group. Pediatr Infect Dis J. 2000;19:319-324
5. Karlowicz MG, Rowen JL, Barnes-Eley ML, et al. The role of birth weight and gestational age in distinguishing extremely low birth weight infants at high risk of developing candidemia from infants at low risk: a multicenter study. Pediatr Res. 2002;51:301A
6. Baley JE, Kliegman RM, Boxerbaum B, Fanaroff AA. Fungal colonization in the very low birth weight infant. Pediatrics. 1986;78:225-232
7. Huang YC, Li CC, Lin TY. Association of fungal colonization and invasive disease in very low birth weight infants. Pediatr Infect Dis J. 1998;17:819-822
8. Pappu-Katikaneni LD, Rao KP, Banister E. Gastrointestinal colonization with yeast species and Candida septicemia in very low birth weight infants. Mycoses. 1990;33:20-23
9. Rowen JL, Rench MA, Kozinetz CA, Adams JM Jr, Baker CJ. Endotracheal colonization with Candida enhances risk of systemic candidiasis in very low birth weight neonates. J Pediatr. 1994;124:789-784
10. Saiman L, Ludington E, Dawson JD, et al. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J. 2001;20:1119-1124
11. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Donowitz LG. Fluconazole prophylaxis against fungal colonization and infection in preterm infants. N Engl J Med. 2001;345:1660-1666
12. Benjamin DK Jr, Ross K, McKinney RE Jr, Benjamin DK, Auten R, Fisher RG. When to suspect fungal infection in neonates: a clinical comparison of Candida albicans and Candida parapsilosis fungemia with coagulase-negative staphylococcal bacteremia. Pediatrics. 2000;106:712-718
13. Benjamin DK, DeLong ER, Steinbach WJ, Cotton CM, Walsh TJ, Clark RH. Empirical therapy for neonatal candidemia in VLBW infants. Pediatrics. 2003;112:543-547
14. Guida JD, Kunig AM, Leef KH, McKenzie SE, Paul DA. Platelet count and sepsis in VLBW neonates: is there an organism-specific response? Pediatrics. 2003;111:1411-1415
15. Pappas PG, Rex JH, Sobel JD, et al. Guidelines for treatment of Candidiasis. Clin Infect Dis. 2004;38:161-189
16. Munoz P, Burillo A, Bouza E. Criteria used when initiating antifungal therapy against Candida spp. in the intensive care unit. Int J Antimicrob Agents. 2000;15:83-90
17. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis. 2002;34:7-14
18. Manzoni P, Pedicino R, Stolfi I, et al. Criteria for the diagnosis of systemic fungal infections in newborns: a report from the Task Force on neonatal fungal infections of the GSIN [in Italian]. Pediatr Med Chir. 2004;26:89-95
19. Gotzsche PC, Johansen HK. Routine versus selective antifungal administration for control of fungal infections in patients with cancer. Cochrane Database Syst Rev. 2002;(2):CD000026
20. Castagnola E, Machetti M, Bucci B, Viscoli C. Antifungal prophylaxis with azole derivatives. Clin Microbiol Infect. 2004;10(suppl 1):86-95
21. Pelz RK, Hendrix CW, Swoboda SM, et al. Double-blind placebo-controlled trial of fluconazole to prevent candidal infections in critically ill surgical patients. Ann Surg. 2001;233:542-548
22. Laverdiere M, Rotstein C, Bow EJ, et al. Impact of fluconazole prophylaxis on fungal colonization and infection rates in neutropenic patients. The Canadian Fluconazole Study. J Antimicrob Chemother. 2000;46:1001-1008
23. Ninane J, Multicentre Study Group. A multicentre study of fluconazole versus oral polyenes in the prevention of fungal infection in children with haematological or oncological malignancies. Eur J Clin Microbiol Infect Dis. 1994;13:30-37
24. Kicklighter SD, Springer SC, Cox T, Hulsey TC, Turner RB. Fluconazole for prophylaxis against candidal rectal colonization in the very low birth weight infant. Pediatrics. 2001;107:293-298
25. Sims ME, Yoo Y, You H, Salminen C, Walther FJ. Prophylactic oral nystatin and fungal infections in very-low-birth-weight infants. Am J Perinatol. 1988;5:33-36
26. Austin NC, Darlow B. Prophylactic oral anti-fungal agents to prevent systemic Candida infection in preterm infants. Cochrane Database Syst Rev. 2004;(1):CD003478
27. Wainer S, Cooper PA, Funk E, Bental RY, Sandler DA, Patel J. Prophylactic miconazole oral gel for the prevention of neonatal fungal rectal colonization and systemic infection. Pediatr Infect Dis J. 1992;11:713-716
28. Neely MN, Schreiber JR. Fluconazole prophylaxis in the very low birth weight infant: not ready for prime time. Pediatrics. 2001;107:404-405
29. McGuire W, Clerihew L, Austin N. Prophylactic intravenous antifungal agents to prevent mortality and morbidity in very low birth weight infants. Cochrane Database Syst Rev. 2004;(1):CD003850
30. Mouzinho A, Rosenfeld CR, Sanchez PJ Risser R. Revised reference ranges for circulating neutrophils in very low birth weight neonates. Pediatrics. 1994;94:76-82
31. Nolla-Salas J, Sitges-Serra A, Leon-Gil C, et al. Candidemia in non neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Intensive Care Med. 1997;23:23-30
32. Karlowicz MG, Hashimoto LN, Kelly RE Jr, Buescher ES. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics. 2000;106(5). Available at: www.pediatrics.org/cgi/content/ full/106/5/e63
33. Huttova M, Filka J, Kurak J, Kralinsky K, Krcmery V. Candida fungaemia in neonates treated with fluconazole. Pediatr Infect Dis J. 1998;17:1112-1116
34. Novelli V, Holzel H. Safety and tolerability of fluconazole in children. Antimicrob Agents Chemother. 1999;43:1955-1960
35. Wenzl TG, Schefels J, Hornchen H, Skopnik H. Pharmacokinetics of oral fluconazole in premature infants. Eur J Pediatr. 1998;157:661-662
36. Brammer KW, Coates PE. Pharmacokinetics of fluconazole in paediatric patients. Eur J Clin Microbiol Infect Dis. 1994;13:325-329
37. National Committee for Clinical Laboratory Standards (NCCLS). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts. Approved Standard M27-A. Wayne, PA: National Committee for Clinical Laboratory Standards; 1997
38. Slotman GJ, Saphiro R, Moffa SM. Fungal sepsis: multisite colonization versus fungemia. Am Surg. 1994;60:107-113
39. Pittet D, Monod M, Suter PM, Frenk E, Auckenthaler R. Candida colonization and subsequent infections in critically ill surgical patients. Am Surg. 1994;6:751-758
40. Nahata MC, Tallian KB, Force RW. Pharmacokinetics of fluconazole in young infants. Eur J Drug Metab Pharmacokinet. 1999;24:155-157
41. Hope W, Morton A, Eisen DP. Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use. J Hosp Infect. 2002;50:56-65
42. Kaufman D, Boyle R, Hazen KC, Patrie JT, Robinson M, Grossmann LB. Sensitivities of Fungal Isolates in High-Risk Preterm Infants Exposed to Fluconazole Prophylaxis in a Neonatal Intensive Care Unit over a 5-Year Period. Poster presented at: the 44th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC; November 2004 (in press)
43. Kaufman D, Dover CM, Reynolds SE, et al. Sensitivity of Candida isolates in high-risk preterm infants exposed to fluconazole prophylaxis in a neonatal intensive care unit over a 6-year period. Pediatric Academic Societies. 2005;57:647